ROS-Triggered Autophagy Is Involved in PFOS-Induced Apoptosis of Human Embryo Liver L-02 Cells

Biomed Res Int. 2021 Apr 5:2021:6625952. doi: 10.1155/2021/6625952. eCollection 2021.

Abstract

The liver is the primary target organ for perfluorooctane sulphonate (PFOS), a recently discovered persistent organic pollutant. However, the mechanisms mediating hepatotoxicity remain unclear. Herein, we explored the relationship between reactive oxygen species (ROS) and autophagy and apoptosis induced by PFOS in L-02 cells, which are incubated with different concentrations of PFOS (0, 50, 100, 150, 200, or 250 μmol/L) for 24 or 48 hrs at 37°C. The results indicated that PFOS exposure decreased cell activities, enhanced ROS levels in a concentration-dependent manner, decreased mitochondrial membrane potential (MMP), and induced autophagy and apoptosis. Compared with the control, 200 μmol/L PFOS increased ROS levels; enhanced the expression of Bax, cleaved-caspase-3, and LC3-II; induced autophagy; decreased MMP; and lowered Bcl-2, p62, and Bcl-2/Bax ratio. The antioxidant N-acetyl cysteine (NAC) protected MMP against PFOS-induced changes and diminished apoptosis and autophagy. Compared with 200 μmol/L PFOS treatment, NAC pretreatment reversed the increase in ROS, Bax, and cleaved-caspase-3 protein caused by PFOS, lowered the apoptosis rate increased by PFOS, and increased the levels of MMP and Bcl-2/Bax ratio decreased by PFOS. The autophagy inhibitor 3-methyladenine and chloroquine decreased apoptosis and cleaved-caspase-3 protein level and increased the Bcl-2/Bax ratio. In summary, our results suggest that ROS-triggered autophagy is involved in PFOS-induced apoptosis in L-02 cells.

MeSH terms

  • Acetylcysteine / pharmacology
  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Alkanesulfonic Acids / pharmacology*
  • Apoptosis* / drug effects
  • Autophagy* / drug effects
  • Cadaverine / pharmacology
  • Cell Line
  • Cell Survival / drug effects
  • Cellular Microenvironment / drug effects
  • Embryo, Mammalian / pathology*
  • Fluorocarbons / pharmacology*
  • Humans
  • Liver / drug effects
  • Liver / embryology*
  • Liver / pathology*
  • Membrane Potential, Mitochondrial / drug effects
  • Proteins / metabolism
  • Reactive Oxygen Species / metabolism*
  • Vacuoles / drug effects
  • Vacuoles / metabolism

Substances

  • Alkanesulfonic Acids
  • Fluorocarbons
  • Proteins
  • Reactive Oxygen Species
  • 3-methyladenine
  • perfluorooctane sulfonic acid
  • Adenine
  • Cadaverine
  • Acetylcysteine